Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

SmithKline Beecham/Human Genome Sciences human genome collaboration no longer exclusive

July 12, 1996

Oculex receives grants for ocular drug delivery research

July 12, 1996

Heliosynthese and Scotia receive EEC Eureka award for microalgae research

July 12, 1996

Phytera and Tsumura Juntendo collaborate in rheumatoid arthritis/allergy R&D

July 12, 1996

Collaboration on signal transduction inhibitor drug discovery announced

July 12, 1996

Arris issued U.S. patent for drug design technology

July 12, 1996

Arris, SKB to research protease inhibitors

July 5, 1996

ArQule, ICAgen collaborate on ion channel modulators

July 5, 1996

Gilead reports important discovery related to genetic code blocker research

July 5, 1996

Eotaxin receptor cloned: Possible implications for asthma research

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...